These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 19527222)

  • 21. Activity and stability of human kallikrein-2-specific linear and cyclic peptide inhibitors.
    Pakkala M; Hekim C; Soininen P; Leinonen J; Koistinen H; Weisell J; Stenman UH; Vepsäläinen J; Närvänen A
    J Pept Sci; 2007 May; 13(5):348-53. PubMed ID: 17436344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unleashing the therapeutic potential of human kallikrein-related serine proteases.
    Prassas I; Eissa A; Poda G; Diamandis EP
    Nat Rev Drug Discov; 2015 Mar; 14(3):183-202. PubMed ID: 25698643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. On the biosynthesis and biological role of eoxins and 15-lipoxygenase-1 in airway inflammation and Hodgkin lymphoma.
    Claesson HE
    Prostaglandins Other Lipid Mediat; 2009 Sep; 89(3-4):120-5. PubMed ID: 19130894
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human Tissue Kallikrein 1 Is Downregulated in Elderly Human Prostates and Possesses Potential In Vitro Antioxidative and Antifibrotic Effects in Rodent Prostates.
    Zhang M; Luo C; Lin D; Cui K; Chen Z; Liu J
    Oxid Med Cell Longev; 2021; 2021():8877540. PubMed ID: 34007408
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of an orally efficacious matrix metalloprotease 12 inhibitor for potential treatment of asthma.
    Li W; Li J; Wu Y; Rancati F; Vallese S; Raveglia L; Wu J; Hotchandani R; Fuller N; Cunningham K; Morgan P; Fish S; Krykbaev R; Xu X; Tam S; Goldman SJ; Abraham W; Williams C; Sypek J; Mansour TS
    J Med Chem; 2009 Sep; 52(17):5408-19. PubMed ID: 19725580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiogenesis in cervical cancer is mediated by HeLa metabolites through endothelial cell tissue kallikrein.
    Naidoo S; Raidoo DM
    Oncol Rep; 2009 Aug; 22(2):285-93. PubMed ID: 19578768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peroxisome proliferator-activated receptor gamma agonist down-regulates IL-17 expression in a murine model of allergic airway inflammation.
    Park SJ; Lee KS; Kim SR; Min KH; Choe YH; Moon H; Chae HJ; Yoo WH; Lee YC
    J Immunol; 2009 Sep; 183(5):3259-67. PubMed ID: 19641141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inflammatory mechanisms and treatment of obstructive airway diseases with neutrophilic bronchitis.
    Simpson JL; Phipps S; Gibson PG
    Pharmacol Ther; 2009 Oct; 124(1):86-95. PubMed ID: 19555716
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tissue kallikrein is essential for invasive capacity of circulating proangiogenic cells.
    Spinetti G; Fortunato O; Cordella D; Portararo P; Kränkel N; Katare R; Sala-Newby GB; Richer C; Vincent MP; Alhenc-Gelas F; Tonolo G; Cherchi S; Emanueli C; Madeddu P
    Circ Res; 2011 Feb; 108(3):284-93. PubMed ID: 21164105
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of tissue kallikrein-related peptidases in cervical mucus remodeling and host defense.
    Shaw JL; Petraki C; Watson C; Bocking A; Diamandis EP
    Biol Chem; 2008 Dec; 389(12):1513-22. PubMed ID: 18844451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blockade of CCR4 in a humanized model of asthma reveals a critical role for DC-derived CCL17 and CCL22 in attracting Th2 cells and inducing airway inflammation.
    Perros F; Hoogsteden HC; Coyle AJ; Lambrecht BN; Hammad H
    Allergy; 2009 Jul; 64(7):995-1002. PubMed ID: 19630858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetically‑modified stem cells in treatment of human diseases: Tissue kallikrein (KLK1)‑based targeted therapy (Review).
    Devetzi M; Goulielmaki M; Khoury N; Spandidos DA; Sotiropoulou G; Christodoulou I; Zoumpourlis V
    Int J Mol Med; 2018 Mar; 41(3):1177-1186. PubMed ID: 29328364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Allergen-induced asthma in C57Bl/6 mice: hyper-responsiveness, inflammation and remodelling.
    Pinelli V; Marchica CL; Ludwig MS
    Respir Physiol Neurobiol; 2009 Oct; 169(1):36-43. PubMed ID: 19686870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of plasma kallikrein by a highly specific active site blocking antibody.
    Kenniston JA; Faucette RR; Martik D; Comeau SR; Lindberg AP; Kopacz KJ; Conley GP; Chen J; Viswanathan M; Kastrapeli N; Cosic J; Mason S; DiLeo M; Abendroth J; Kuzmic P; Ladner RC; Edwards TE; TenHoor C; Adelman BA; Nixon AE; Sexton DJ
    J Biol Chem; 2014 Aug; 289(34):23596-608. PubMed ID: 24970892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emerging oligonucleotide therapies for asthma and chronic obstructive pulmonary disease.
    Séguin RM; Ferrari N
    Expert Opin Investig Drugs; 2009 Oct; 18(10):1505-17. PubMed ID: 19715448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evolution of kallikrein-related peptidases in mammals and identification of a genetic locus encoding potential regulatory inhibitors.
    Lundwall A; Clauss A; Olsson AY
    Biol Chem; 2006 Mar; 387(3):243-9. PubMed ID: 16542144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulatory T cells negatively regulate neovasculature of airway remodeling via DLL4-Notch signaling.
    Huang MT; Dai YS; Chou YB; Juan YH; Wang CC; Chiang BL
    J Immunol; 2009 Oct; 183(7):4745-54. PubMed ID: 19752226
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of XPA067.06, a potent high affinity human anti-gastrin monoclonal antibody.
    Hsu SJ; Patel A; Larsen PD; Bohmann DJ; Bauer RJ; Ma JK; Masat L; Roell M; Babuka SJ; Hansen RK; White M; Haak-Frendscho M
    Biochem Pharmacol; 2008 Aug; 76(3):340-52. PubMed ID: 18589401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tissue remodeling induced by hypersecreted epidermal growth factor and amphiregulin in the airway after an acute asthma attack.
    Enomoto Y; Orihara K; Takamasu T; Matsuda A; Gon Y; Saito H; Ra C; Okayama Y
    J Allergy Clin Immunol; 2009 Nov; 124(5):913-20.e1-7. PubMed ID: 19895983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human tissue kallikreins as promiscuous modulators of homeostatic skin barrier functions.
    Eissa A; Diamandis EP
    Biol Chem; 2008 Jun; 389(6):669-80. PubMed ID: 18627299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.